Increased levels of palmitoylethanolamide and other bioactive lipid mediators and enhanced local mast cell proliferation in canine atopic dermatitis
Open Access
- 14 January 2014
- journal article
- research article
- Published by Springer Science and Business Media LLC in BMC Veterinary Research
- Vol. 10 (1), 21
- https://doi.org/10.1186/1746-6148-10-21
Abstract
Despite the precise pathogenesis of atopic dermatitis (AD) is still unknown, an immune dysregulation that causes Th2-predominant inflammation and an intrinsic defect in skin barrier function are currently the two major hypotheses, according to the so-called outside-inside-outside model. Mast cells (MCs) are involved in AD both by releasing Th2 polarizing cytokines and generating pruritus symptoms through release of histamine and tryptase. A link between MCs and skin barrier defects was recently uncovered, with histamine being found to profoundly contribute to the skin barrier defects.Keywords
This publication has 68 references indexed in Scilit:
- Canine atopic dermatitis – what have we learned?Veterinary Record, 2013
- Histamine suppresses epidermal keratinocyte differentiation and impairs skin barrier function in a human skin modelAllergy, 2012
- Effects of palmitoylethanolamide on the cutaneous allergic inflammatory response in Ascaris hypersensitive Beagle dogsThe Veterinary Journal, 2012
- β−Amyloid exacerbates inflammation in astrocytes lacking fatty acid amide hydrolase through a mechanism involving PPAR‐α, PPAR‐γ and TRPV1, but not CB1 or CB2 receptorsBritish Journal of Pharmacology, 2012
- Palmitoylethanolamide Reduces Granuloma-Induced Hyperalgesia by Modulation of Mast Cell Activation in RatsMolecular Pain, 2011
- Effects of palmitoylethanolamide on immunologically induced histamine, PGD2 and TNFα release from canine skin mast cellsVeterinary Immunology and Immunopathology, 2010
- Mast cells in atopic dermatitisCurrent Opinion in Immunology, 2009
- New roles for mast cells in modulating allergic reactions and immunity against pathogensCurrent Opinion in Immunology, 2009
- Biosynthesis, degradation and pharmacological importance of the fatty acid amidesDrug Discovery Today, 2008
- Involvement of the cannabimimetic compound, N-palmitoyl-ethanolamine, in inflammatory and neuropathic conditions: Review of the available pre-clinical data, and first human studiesNeuropharmacology, 2005